Insider Transactions in Q1 2025 at Mineralys Therapeutics, Inc. (MLYS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 13
2025
|
Jon Congleton Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,333
-2.05%
|
$164,997
$9.06 P/Share
|
|
Jan 13
2025
|
David Malcom Rodman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,367
+3.53%
|
$0
$0.81 P/Share
|
|
Jan 13
2025
|
Adam Scott Levy CFO and Secretary |
SELL
Open market or private sale
|
Direct |
10,757
-2.27%
|
$96,813
$9.36 P/Share
|